ART Advanced Research Technologies Inc. (“ART”)(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce its participation at the 2006 edition of BIOMEDEX, to be held at the Hilton Bonaventure Hotel in Montreal. Ms. Micheline Bouchard, President & CEO, will present key points of ART’s recent acquisition of Alerion Biomedical Inc., during a panel discussion entitled: “To what extent will setting up a foreign presence give you greater access to liquidity?” The presentation will take place on May 24, 2006, at 2:45 p.m. in the Frontenac Room.
